Understanding Health Care Costs in a Wisconsin Acute Leukemia Population
Purpose: We investigated factors driving health care costs of patients with a diagnosis of acute myeloid and acute lymphoblastic leukemia. Methods: Standard costs identified in insurance claims data obtained from the Wisconsin Health Information Organization were used in a sample of 837 acute le...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Advocate Aurora Health
2016-08-01
|
Series: | Journal of Patient-Centered Research and Reviews |
Subjects: | |
Online Access: | http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1261&context=jpcrr |
_version_ | 1797934742349283328 |
---|---|
author | Patricia Steinert Ron A. Cisler |
author_facet | Patricia Steinert Ron A. Cisler |
author_sort | Patricia Steinert |
collection | DOAJ |
description | Purpose: We investigated factors driving health care costs of patients with a diagnosis of acute myeloid and acute lymphoblastic leukemia.
Methods: Standard costs identified in insurance claims data obtained from the Wisconsin Health Information Organization were used in a sample of 837 acute leukemia patients from April 2009 to June 2011. The Andersen behavioral model of health care utilization guided selection of patient and community factors expected to influence health care costs. A generalized linear model fitting gamma-distributed data with log-link technique was used to analyze cost.
Results: Type of treatment received and disease severity represented significant cost drivers, and patients receiving at least some of their treatment from academic medical centers experienced higher costs. Inpatient care and pharmacy costs of patients who received treatment from providers located in areas of higher poverty experienced lower costs, raising questions of potential treatment and medical practice disparities between provider locations. Directions of study findings were not consistent between different types of services received and underscore the complexity of investigating health care cost.
Conclusions: While prevalence of acute leukemia in the United States is low compared to other diseases, its extreme high cost of treatment is not well understood and potentially influences treatment decisions. Acute leukemia health care costs may not follow expected patterns; further exploration of the relationship between cost and the treatment decision, and potential treatment disparities between providers in different socioeconomic locations, is needed. |
first_indexed | 2024-04-10T18:03:36Z |
format | Article |
id | doaj.art-38ee87b6a00c43c4863f6f920ae4ace4 |
institution | Directory Open Access Journal |
issn | 2330-0698 |
language | English |
last_indexed | 2024-04-10T18:03:36Z |
publishDate | 2016-08-01 |
publisher | Advocate Aurora Health |
record_format | Article |
series | Journal of Patient-Centered Research and Reviews |
spelling | doaj.art-38ee87b6a00c43c4863f6f920ae4ace42023-02-02T14:11:03ZengAdvocate Aurora HealthJournal of Patient-Centered Research and Reviews2330-06982016-08-013314214910.17294/2330-0698.1261Understanding Health Care Costs in a Wisconsin Acute Leukemia PopulationPatricia Steinert0Ron A. Cisler1Medical College of Wisconsin, Milwaukee, WIUniversity of Wisconsin-Milwaukee, Milwaukee, WIPurpose: We investigated factors driving health care costs of patients with a diagnosis of acute myeloid and acute lymphoblastic leukemia. Methods: Standard costs identified in insurance claims data obtained from the Wisconsin Health Information Organization were used in a sample of 837 acute leukemia patients from April 2009 to June 2011. The Andersen behavioral model of health care utilization guided selection of patient and community factors expected to influence health care costs. A generalized linear model fitting gamma-distributed data with log-link technique was used to analyze cost. Results: Type of treatment received and disease severity represented significant cost drivers, and patients receiving at least some of their treatment from academic medical centers experienced higher costs. Inpatient care and pharmacy costs of patients who received treatment from providers located in areas of higher poverty experienced lower costs, raising questions of potential treatment and medical practice disparities between provider locations. Directions of study findings were not consistent between different types of services received and underscore the complexity of investigating health care cost. Conclusions: While prevalence of acute leukemia in the United States is low compared to other diseases, its extreme high cost of treatment is not well understood and potentially influences treatment decisions. Acute leukemia health care costs may not follow expected patterns; further exploration of the relationship between cost and the treatment decision, and potential treatment disparities between providers in different socioeconomic locations, is needed.http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1261&context=jpcrrheatlh care costsacute leukemia costadministrative data use |
spellingShingle | Patricia Steinert Ron A. Cisler Understanding Health Care Costs in a Wisconsin Acute Leukemia Population Journal of Patient-Centered Research and Reviews heatlh care costs acute leukemia cost administrative data use |
title | Understanding Health Care Costs in a Wisconsin Acute Leukemia Population |
title_full | Understanding Health Care Costs in a Wisconsin Acute Leukemia Population |
title_fullStr | Understanding Health Care Costs in a Wisconsin Acute Leukemia Population |
title_full_unstemmed | Understanding Health Care Costs in a Wisconsin Acute Leukemia Population |
title_short | Understanding Health Care Costs in a Wisconsin Acute Leukemia Population |
title_sort | understanding health care costs in a wisconsin acute leukemia population |
topic | heatlh care costs acute leukemia cost administrative data use |
url | http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1261&context=jpcrr |
work_keys_str_mv | AT patriciasteinert understandinghealthcarecostsinawisconsinacuteleukemiapopulation AT ronacisler understandinghealthcarecostsinawisconsinacuteleukemiapopulation |